Association of Vasopressors Dose Trajectories with Enteral Nutrition Tolerance in Patients with Shock: A Prospective Observational Study.
Luping Wang, Tao Zhang, Hua Yao...
https://pubmed.ncbi.nlm.nih.gov/36558552/Actively Recruiting
Led by Başakşehir Çam & Sakura City Hospital · Updated on 2026-09-03
63
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are examining how different doses of vasopressor medications, which help maintain blood pressure in shock, impact gastric emptying during tube feeding in critically ill patients in the intensive care unit ICU. The study focuses on patients receiving enteral nutrition and investigates the relationship between vasopressor dose and gastric motility, aiming to improve feeding tolerance and reduce aspiration risks. It is a prospective observational cohort study led by Baakehir am & Sakura City Hospital. Participants are divided into three groups based on their norepinephrine equivalent dose NEQ no vasopressor use, low-to-moderate dose, and high dose. Gastric emptying is measured using bedside gastric ultrasound at three time points before feeding after a 2-hour fast, and then one and two hours after restarting enteral nutrition. Ultrasound measurements include antrum cross-sectional area and gastric volume, with nasogastric aspiration used to record gastric residual volume. During the study, a blinded ICU fellow performs all ultrasound assessments to ensure consistent results. Researchers will measure the gastric emptying rate over two hours as the primary outcome and also track gastroparesis incidence and enteral nutrition intolerance within 24 hours. Additional analyses will explore the impact of shock type on gastric emptying. The study runs from September 2026 to November 2027, involving continuous monitoring and data collection in the ICU setting.
CONDITIONS
Gastric Emptying and Enteral Nutrition Tolerance According to Vasopressor Dose in ICU Patients
R
Rezan Şerefoğlu, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Başakşehir Çam & Sakura City Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 hours
Participants undergo bedside gastric ultrasound assessments before and after a 2-hour fasting period, with enteral nutrition restarted and further ultrasound measurements at 1 and 2 hours after feeding begins.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Luping Wang, Tao Zhang, Hua Yao...
https://pubmed.ncbi.nlm.nih.gov/36558552/Anahi Perlas, Vincent W S Chan, Catalin M Lupu...
https://pubmed.ncbi.nlm.nih.gov/19512861/Laura Evans, Andrew Rhodes, Waleed Alhazzani...
https://pubmed.ncbi.nlm.nih.gov/34599691/Başakşehir Çam & Sakura City Hospital
Lead Sponsor